These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27574399)

  • 21. Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies.
    Omboni S; Malacco E; Mallion JM; Volpe M; Zanchetti A;
    J Hypertens; 2012 Jul; 30(7):1468-77. PubMed ID: 22573127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy.
    Zhu JR; Zhang SY; Gao PJ
    Arch Pharm Res; 2014 Dec; 37(12):1588-98. PubMed ID: 25060946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial.
    Bae JC; Min KW; Kim YH; Kim KA; Hong EG; Park CY; Han S; Cha BS
    Diabetes Obes Metab; 2019 Jan; 21(1):103-111. PubMed ID: 30084112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.
    Liberopoulos EN; Moutzouri E; Rizos CV; Barkas F; Liamis G; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):113-8. PubMed ID: 23113965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effects of olmesartan on ambulatory blood pressures and blood pressure variability in patients with mild to moderate essential hypertension].
    Li J; Qin T; Jiang H; Wang H; Ke Y
    Zhonghua Nei Ke Za Zhi; 2014 Oct; 53(10):788-92. PubMed ID: 25567150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
    Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM; Heagerty A; Laeis P
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
    Rosenbaum D; Girerd X
    Curr Med Res Opin; 2012 Feb; 28(2):179-86. PubMed ID: 22114906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy/safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertension.
    Punzi HA; Lewin A; Li W; Chavanu KJ
    Adv Ther; 2012 Jun; 29(6):524-37. PubMed ID: 22763801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia.
    Rhee MY; Ahn T; Chang K; Chae SC; Yang TH; Shim WJ; Kang TS; Ryu JK; Nah DY; Park TH; Chae IH; Park SW; Lee HY; Tahk SJ; Yoon YW; Shim CY; Shin DG; Seo HS; Lee SY; Kim DI; Kwan J; Joo SJ; Jeong MH; Jeong JO; Sung KC; Kim SY; Kim SH; Chun KJ; Oh DJ
    BMC Pharmacol Toxicol; 2017 Jan; 18(1):2. PubMed ID: 28057081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
    Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
    Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.
    Neutel JM; Cushman WC; Lloyd E; Barger B; Handley A
    J Clin Hypertens (Greenwich); 2017 Sep; 19(9):874-883. PubMed ID: 28681550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs.
    Stumpe KO; Ludwig M
    J Hum Hypertens; 2002 May; 16 Suppl 2():S24-8. PubMed ID: 11967729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements.
    Neutel J; Elliott WJ; Izzo J; Chen CL; Masonson H
    J Clin Hypertens (Greenwich); 2002; 4(5):325-31. PubMed ID: 12368570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study.
    Chung S; Ko YG; Kim JS; Kim BK; Ahn CM; Park S; Hong SJ; Lee SH; Choi D
    Cardiol J; 2022; 29(5):815-823. PubMed ID: 33346375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of rosuvastatin/olmesartan fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
    Son H; Roh H; Lee D; Chang H; Kim J; Yun C; Park K
    Clin Ther; 2013 Jul; 35(7):915-22. PubMed ID: 23810276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.